IVP(Delisted)
Inspire Veterinary·NASDAQ
--
--(--)
Inspire Veterinary (IVP) Financial Statements
Inspire Veterinary (IVP) Cash Flow Statement
During Q3 2025, Inspire Veterinary (IVP) generated -1.28M in cash flow from operating activities, -43.46K from investing activities, and 1.51M from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2022 | Q1,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2022 | Jan 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2022 | Mar 31, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -828.13K -- | -309.45K +62.63% | -2.56M -- | -754.78K -- | -3.17M -924.07% | 149.72K -- | -6.31M -146.54% | -677.53K +10.24% | -1.37M +56.63% | -898.28K -699.99% | -1.28M +79.67% | -4.23M -- |
Net Income | -- -- | -- -- | -7.88M -- | -4.14M -- | -3.42M -- | -3.39M -- | -3.49M +55.74% | -3.97M +4.23% | -2.42M +29.42% | -3.03M +10.39% | -2.53M +27.60% | -11.94M -- |
Depreciation and Amortization | 428.99K -- | 670.37K +56.27% | 342.19K -- | 382.23K -- | 401.21K -40.15% | 553.90K -- | 342.54K +0.10% | 369.95K -3.21% | 353.12K -11.99% | 311.82K -43.70% | 383.92K +12.08% | 1.42M -- |
Stock-based Compensation | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 23.65K -- | 0 -- | -- -- | 139.27K -- | 0 -100.00% | -- -- |
Impairment of Assets | -- -- | -- -- | -- -- | 123.51K -- | -- -- | -- -- | -- -- | 56.66K -54.12% | -- -- | -- -- | -- -- | -- -- |
Change in Working Capital | -334.38K -- | 556.42K +266.41% | 426.45K -- | 1.54M -- | -2.18M -491.53% | 1.52M -- | -3.86M -1005.91% | 2.08M +34.98% | 421.40K +119.34% | 465.07K -69.34% | 9.77K +100.25% | 2.98M -- |
Change in Accounts Receivable | -- -- | -- -- | -142.41K -- | 89.55K -- | -312.92K -- | 301.77K -- | -75.83K +46.75% | 74.88K -16.38% | 36.30K +111.60% | -179.26K -159.40% | 154.93K +304.31% | 86.85K -- |
Change in Inventories | -- -- | -- -- | 21.56K -- | 183.21K -- | 25.85K -- | -28.93K -- | -31.45K -245.84% | 46.95K -74.38% | 41.50K +60.52% | 38.16K +231.89% | -20.62K +34.42% | 105.98K -- |
Change in Accounts Payable | -- -- | -- -- | 204.06K -- | 905.14K -- | 315.17K -- | 196.21K -- | -1.64M -905.82% | -94.08K -110.39% | -209.51K -166.48% | 105.45K -46.26% | -175.17K +89.35% | -373.32K -- |
Change in Other Working Capital | -- -- | -- -- | 343.24K -- | 363.05K -- | -2.21M -- | 1.05M -- | -2.11M -715.20% | 2.05M +465.28% | 553.12K +125.07% | 500.72K -52.22% | 50.63K +102.40% | 3.16M -- |
Other Non-cash Adjustments | -- -- | -- -- | 4.56M -- | 1.34M -- | 2.03M -- | 1.47M -- | 677.41K -85.13% | 782.57K -41.63% | 266.22K -86.89% | 1.22M -16.73% | 849.89K +25.46% | 3.12M -- |
Net Cash Flows from Investing Activities | -4.41M -- | -14.00K +99.68% | -240.55K -- | -1.51M -- | -156.94K -1020.88% | -23.69K -- | -25.52K +89.39% | -31.83K +97.89% | -20.27K +87.08% | -1.86M -7761.97% | -43.46K -70.31% | -1.96M -- |
Change in PPE and Intangible Assets | -- -- | -- -- | -240.55K -- | -19.63K -- | -156.94K -- | -23.69K -- | -25.52K +89.39% | -31.83K -62.12% | -20.27K +87.08% | -12.58K +46.90% | -43.46K -70.31% | -108.14K -- |
Purchase of PPE and Intangible Assets | -- -- | 14.00K -- | 240.55K -- | 19.63K -- | 156.94K +1020.88% | 23.69K -- | 25.52K -89.39% | 31.83K +62.12% | 20.27K -87.08% | 12.58K -46.90% | 43.46K +70.31% | 108.14K -- |
Change in long-term Equity Investments | -- -- | -- -- | 0 -- | -1.49M -- | -- -- | 0 -- | 0 -- | 0 +100.00% | -- -- | -1.85M -- | 0 -- | -- -- |
Change in Subsidiaries | -- -- | -- -- | 0 -- | -1.49M -- | -- -- | 0 -- | 0 -- | 0 +100.00% | -- -- | -1.85M -- | 0 -- | -- -- |
Other Investing Activities | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Cash Flows from Financing Activities | 4.81M -- | 473.07K -90.17% | 3.89M -- | 682.79K -- | 3.22M +579.84% | -187.44K -- | 7.01M +80.03% | 551.85K -19.18% | 2.53M -21.37% | 1.30M +791.55% | 1.51M -78.47% | 5.89M -- |
Change in Debt | -- -- | -- -- | -1.55M -- | 682.79K -- | -359.37K -- | -187.44K -- | -1.95M -26.19% | -1.15M -268.39% | -1.33M -269.56% | 1.30M +791.55% | -713.70K +63.44% | -1.90M -- |
Change in Capital Stock | -- -- | -- -- | 5.44M -- | 0 -- | 3.58M -- | 0 -- | 8.96M +64.72% | 1.70M -- | 3.86M +7.87% | 0 -- | 2.22M -75.19% | 7.78M -- |
Increase in Capital Stock | -- -- | -- -- | 5.44M -- | 0 -- | 3.58M -- | 0 -- | 8.96M +64.72% | 2.35M -- | 3.86M +7.87% | 0 -- | 2.22M -75.19% | 8.43M -- |
Decrease in Capital Stock | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 650.00K -- | -- -- | -- -- | 0 -- | -- -- |
Other Financing Activities | -- -- | -- -- | 0 -- | 1 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Increase in Cash and Cash Equivalents | -422.90K -- | 149.61K +135.38% | 1.09M -- | -1.58M -- | -109.88K -173.45% | -61.42K -- | 673.54K -38.39% | -157.51K +90.01% | 1.13M +1132.31% | -1.46M -2284.59% | 182.80K -72.86% | -304.95K -- |
Cash and Cash Equivalents at Beginning of Period | 2.06M -- | 444.25K -78.42% | 863.18K -- | 1.96M -- | 378.96K -14.70% | 269.08K -- | 207.66K -75.94% | 881.20K -54.96% | 723.69K +90.97% | 1.86M +590.52% | 393.44K +89.47% | 3.86M -- |
Cash and Cash Equivalents at End of Period | 1.64M -- | 593.87K -63.69% | 1.96M -- | 378.96K -- | 269.08K -54.69% | 207.66K -- | 881.20K -54.96% | 723.69K +90.97% | 1.86M +590.52% | 393.44K +89.47% | 576.25K -34.61% | 3.55M -- |
You can ask Aime
No Data
